Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Researchers led by Mass General Brigham report that older adults who took a daily multivitamin for two years showed signs of slower biological aging. The effect was strongest among participants who ...

Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing ...

Clinical research has always been the backbone of medical progress, providing the data and insights needed to develop new treatments, improve patient outcomes, and advance public health. Yet, the ...

In a partnership between the UCSF School of Nursing and UCSF Health, nursing experts are mentoring UCSF Health bedside nurses ...

GOTHENBURG, SE / ACCESS Newswire / March 17, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that i ...

NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Today, Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance, announced the expansion of its proven peer-to-peer clinical research education ...

Clinical trials can vary in length depending on several factors. Here's what you need to know about how long clinical trials last.

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...

Raleigh, NC - March 16, 2026 - PRESSADVANTAGE - Porter Ophthalmology has opened a dedicated Office-Based Surgery suite ...